Structured approach to treat patients with acute liver failure: A hepatic emergency
Authors:
Open Access
- 1 January 2012
- journal article
- review article
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 16 (1) , 1-7
Abstract
Acute liver failure (ALF) is a condition of acute hepatic emergency where rapid deterioration of hepatocyte function leads to hepatic encephalopathy, coagulopathy, cerebral edema (CE), infection and multi-organ dysfunction syndrome resulting in a high mortality rate. Urgent liver transplantation is the standard of care for most of these patients in Western countries. However, in India, access to liver transplantation is severely limited and, hence, the management is largely based on intensive medical care. With earlier recognition of disease, better understanding of pathophysiology and improved intensive care, ALF patients have shown a significant improvement in spontaneous survival. An evidence base for practice for supportive care is still lacking; however, intensive organ support as well as control of infection and CE are likely to be key to the successful outcome in this acute and potentially reversible condition without any sequel. A structured approach to decision making about intensive care is important in each case. Unlike in Western countries where acetamenophen is the most common cause of ALF, the role of a specific agent, such as N-acetylcysteine, is limited in India. Ammonia-lowering therapy is still in an evolving phase. The current review highlights the important medical management issues in patients with ALF in general as well as the management of major complications associated with ALF. We performed a MEDLINE search using combinations of the key words such as acute liver failure, intensive treatment of acute liver failure and fulminant hepatic failure. We reviewed the relevant publications with regard to intensive care of patients with ALF.Keywords
This publication has 77 references indexed in Scilit:
- Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver FailureGastroenterology, 2009
- Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic supportJournal of Hepatology, 2007
- Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure—a controlled clinical trialJournal of Hepatology, 2004
- The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failureHepatology, 2004
- Acute liver failure: Results of a 5-year clinical protocolLiver Transplantation and Surgery, 1995
- The safety and value of extradural intracranial pressure monitors in fulminant hepatic failureJournal of Hepatology, 1993
- Nutritional Therapies in Liver DiseaseSeminars in Liver Disease, 1991
- Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen OverdoseNew England Journal of Medicine, 1988
- Lactulose-induced megacolonGastrointestinal Endoscopy, 1988
- Randomised trial of steroid therapy in acute liver failure. Report from the European Association for the Study of the Liver (EASL).Gut, 1979